Geisel School of Medicine at Dartmouth, Hanover, NH 03756, USA.
Section of Pain Medicine, Department of Anesthesiology, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA.
Med Sci (Basel). 2022 Jul 25;10(3):39. doi: 10.3390/medsci10030039.
Vasovagal reactions are a benign but common outcome of interventional pain management procedures that can negatively impact patient care, including aborted procedures and fear of future procedures that would otherwise help the patient. Research has been done on the incidence, risk factors, and management of vasovagal reactions resulting from such procedures, but less is known about how to prevent these reactions from occurring. In this paper, we present a literature review of the pathophysiology, incidence, risk factors, prevention, and management of vasovagal reactions during interventional pain management procedures, with an emphasis on the relative lack of research and conflicting advice on preventive measures. We found that moderate sedation and anxiolytics have been used prophylactically to prevent vasovagal reactions, but their side-effect profiles prevent them from being used commonly. Less studied is the prophylactic administration of antimuscarinics and IV fluids, despite the potential benefit of these measures and relatively low side-effect profile. We explore these topics here and offer advice for future research to fill the gaps in our knowledge.
血管迷走神经性反应是介入性疼痛管理程序的一种良性但常见的结果,会对患者护理产生负面影响,包括手术中断和对未来可能有助于患者的手术的恐惧。已经对这些手术引起的血管迷走神经性反应的发生率、风险因素和管理进行了研究,但对于如何预防这些反应的发生知之甚少。在本文中,我们对介入性疼痛管理程序中血管迷走神经性反应的病理生理学、发生率、风险因素、预防和管理进行了文献回顾,重点介绍了预防措施方面相对缺乏研究和相互矛盾的建议。我们发现,中度镇静和抗焦虑药已被预防性用于预防血管迷走神经性反应,但它们的副作用阻止了它们的广泛使用。预防性使用抗毒蕈碱药物和静脉输液的研究较少,尽管这些措施可能带来益处,且副作用相对较低。我们在这里探讨了这些话题,并为未来的研究提供了建议,以填补我们知识中的空白。